论文部分内容阅读
目的:应用糖皮质激素对肿瘤内科患者的治疗干预效果进行初步探讨。方法:收集2014年2月—2015年2月期间的20例肿瘤内科患者有关资料,将患者平均分为两组,观察组患者每日应用糖皮质激素不超过40毫克,对照组患者每日应用糖皮质激素不少于40毫克,比较两组患者在不同剂量下并发症及产生不良反应的缓解程度。结果:在抗肿瘤治疗中肿瘤水肿、过敏、体力消耗、产生不良反应或并发症等方面,观察组患者的改善情况显著高于对照组患者,两组之间存在的差异具有统计意义(P<0.05)。结论:在肿瘤患者抗肿瘤治疗中,结合患者病情应用糖皮质激素,选择适宜药物剂量,能够使患者在化疗中产生的不良反应得到明显缓解,减轻患者痛苦,对于提高患者抗肿瘤治疗效果具有重要作用。
Objective: To investigate the effect of glucocorticoid treatment intervention in oncology patients. Methods: Twenty cases of medical oncology patients from February 2014 to February 2015 were collected. The patients were equally divided into two groups. The observation group received no more than 40 mg glucocorticoids daily, and the control group patients were daily applied Glucocorticoids not less than 40 mg, comparisons of two groups of patients at different doses of complications and adverse reactions caused by the degree of remission. Results: In the anti-tumor treatment of tumor edema, allergy, physical exertion, adverse reactions or complications, the observation group patients improved significantly higher than the control group patients, the difference between the two groups was statistically significant (P < 0.05). Conclusion: In the anti-cancer treatment of cancer patients, the combination of glucocorticoid in patients with the condition, select the appropriate dose of drugs, patients can be adverse reactions in chemotherapy were significantly alleviated, reduce patient pain, for improving the anti-cancer treatment of patients is important effect.